Vasoactive drug treatment for heart failure-related cardiogenic shock may include:
a) Inotropes (e.g., dobutamine, milrinone) to improve cardiac contractility
b) Vasopressors (e.g., norepinephrine, dopamine) to increase systemic vascular resistance and blood pressure
c) Vasodilators (e.g., nitroglycerin, nitroprusside) to reduce preload and afterload
d) Combination therapy tailored to the individual patient's hemodynamic profile and response to initial therapy